New Kinase Inhibitor Effective against Drug-Resistant Leukemia, Preclinical Study Finds
March 21, 2016
A novel compound developed at the University of North Carolina at Chapel Hill has shown promise in preclinical studies as a treatment for acute myeloid leukemia, more than doubling median days of survival even in a drug-resistant form of the … Read more